Characterization of Imidazoline Receptors by Radioligand Binding

  • Alan L. Hudson
  • Lisa A. Lione
Part of the Methods in Molecular Biology book series (MIMB, volume 106)


Imidazoline receptors are divided into two main types, known as I1- and I2-receptors, and whereas I1 receptors appear to play a role in control of blood pressure, I2 receptor mediated functions are still unclear (1).


Assay Buffer Binding Study Receptor Binding Assay Radioligand Binding Study Imidazoline Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Bousquet, P. (1997). Imidazoline receptors. Neurochem Int. 30, 3–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Ernsberger, P., Graves, M. E., Graff, L. M., Zakieh, N., Nguyen, P., Collins, L. A., Westbrooks, K. L., and Johnson, G. G. (1995) I1-Imidazoline receptors. New York Acad. Sci. 763, 22–42.CrossRefGoogle Scholar
  3. 3.
    Ernsberger, P., Piletz, J. E., Graft, L. M., and Graves, M. E. (1995) Optimization of radioligand binding assays for I1-imidazoline sites. New York Acad. Sci. 763, 163–168.CrossRefGoogle Scholar
  4. 4.
    Separovic, D., Kester, M., and Ernsberger, P. (1996) Coupling of I1-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells. Mol. Pharmacol. 49, 668–675.PubMedGoogle Scholar
  5. 5.
    Li, G., Regunathan, S., Barrow, C. J., Eshragi, J., Cooper, R., and Reis, D. J. (1994) Agmatine: an endogenous clonidine displacing substance in the brain. Science 263, 966–969.PubMedCrossRefGoogle Scholar
  6. 6.
    Mallard, N. J., Hudson, A. L., and Nutt, D. J. (1992) Characterisation and autoradiographical localisation of non-adrenoceptor idazoxan binding sites in the rat brain. Br. J. Pharmacol. 106, 1019–1027.PubMedGoogle Scholar
  7. 7.
    Lione, L. A., Nutt, D. J., and Hudson, A. L. (1996) [3H]2-(2-Benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. Eur. J. Pharmacol. 304, 221–229.PubMedCrossRefGoogle Scholar
  8. 8.
    Lanier, S. M., Ivkovic, B., Singh, I., Neumeyer, J. L., and Bakthavachalam, V. (1993) Visualisation of multiple imidazoline/guainidium-receptive sites. J. Biol. Chem. 268, 16,047–16,051.PubMedGoogle Scholar
  9. 9.
    Parini, A., Moudanos, C. G., Pizzinat, N., and Lanier, S. M. (1996) The elusive family of imidazoline binding sites. Trends Pharmacol. Sci. 17, 13–16.PubMedCrossRefGoogle Scholar
  10. 10.
    Sastre, M. and García-Sevilla, J. A. (1997) Densities of I2-imidazoline receptors, α2-adrenoceptors and monoamine oxidase in brains of suicide victims. Neurochem. Int. 30, 63–72.PubMedCrossRefGoogle Scholar
  11. 11.
    Morgan, N. G., Chan, S. L., Brown, C. A., and Efthymia, T. (1995) Characterisation of the imidazoline binding site involved in regulation of insulin secretion. New York Acad. Sci. 763, 361–373.CrossRefGoogle Scholar
  12. 12.
    Cheng, Y. C. and Pru, W. H. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 1999

Authors and Affiliations

  • Alan L. Hudson
    • 1
  • Lisa A. Lione
    • 1
  1. 1.Psychopharmacology Unit, School of Medical SciencesUniversity of BristolUK

Personalised recommendations